太化股份(600281.SH)半年度營收2.01億元同比下降37%
格隆匯8月16日丨太化股份(600281.SH)發佈2019年半年度報告,實現營業收入2.01億元,同比下降37%;歸屬於上市公司股東的淨虧損2385.55萬元,同比收窄33.55%;基本每股虧損0.0464元。
上半年,公司充分利用在貴金屬回收加工的技術優勢和貿易業務資源,在嚴控風險的基礎上,加強管理,規範流程,強化服務,增加收益,使公司現有生產經營平穩運行,提高了盈利水平。公司結合國家和省內經濟結構調整、產業佈局的新政策導向,做了大量調研和論證工作,並有意嘗試和擴展新業務。
2019年下半年,公司將加大力度實施現有產能的達產達效工作和新項目的落地,拓展和涉足新的業務領域,加快實現公司轉型發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.